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The Ras-ERK cell signaling regulates transcription of DNA methyl-transferases (DNMTs). A role of H2S in 
regulation of the Ras-ERK signaling activity and DNMTs expression has also been shown. Here we propose 
a hypothesis that H2S regulates the Ras-ERK signaling-dependent DNMTs transcription. Oxidative stress, li-
pid metabolism, protein sulfhydration, nitrosylation and nitration are the main targets of regulation by H2S. 
These cell processes are important for the post-translational modifications (PTMs) of the Ras-ERK signaling 
pathway enzymes. We provide  evidence for the dependence of DNMTs transcription on the PTMs of the en-
zymes of the Ras-ERK signaling pathway regulated by H2S.
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Introduction
DNMTs are the group of enzymes that catalyze 
methylation of cytosine nucleic acids in CpG dinu-
cleotide sequences of DNA. The product of this re-
action is 5-methylcytosine (Fig. 1) [1, 2]. The main 
substrate of DNMTs is 
S-adenosinemethionine (SAM) converted to 
S-adenosinehomocysteine (SAH) as a result of the 
reaction. SAH is a DNMTs concurrent inhibitor that 
is why SAH utilization is important for the DNMTs 
activity [3]. The methionine cycle is a cascade of re-
actions which provides the SAM biosynthesis and 
SAH utilization [3, 4]. 
In the last decade more attention has been paid to 
the metabolite of the methionine cycle hydrogen sul-
fide (H2S). H2S is biosynthesized by many organ-
isms, including humans. There are three basic routes 
of H2S biosynthesis in humans: 1) enzymatic con-
densation of two homocysteine molecules (30 % of 
total H2S production); 2) enzymatic condensation of 
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Fig. 1. A – Schematic representation of the conversion of cyto-
sine to 5-methylcytosine (the author). B – Schematic representa-
tion of the main enzymatic routes of H2S biosynthesis in humans 
(the author).
410
T. A. Nikitina
cysteine and homocysteine (25–70 % of total H2S 
production); 3) enzymatic cysteine conversion to 
H2S, pyruvate and NH4+. The second reaction is 
catalyzed by Cystationine-beta-Synthase (CBS) oth-
ers are catalyzed by Cystathionine-gamma-Lyase 
(CSE) [5, 6].It is now known that H2S is a substrate 
for post-translational modification of a protein, 
called sulfhydration [7]. Furthermore, H2S is an im-
portant element of the antioxidant system [8], as 
well as a regulator of the lipid [9–12] and NO me-
tabolism [13–16]. 
We hypothesized an important role of H2S in the 
Ras-ERK signaling pathway regulation of the 
DNMTs transcription through above-mentioned 
mechanisms. Indeed, there are a lot of studies on the 
Ras-ERK signaling and DNMTs transcription regu-
lation by H2S upon the oxidative stress conditions 
[17–19]. We also pointed out to the proteine sulfhy-
dration and nitrosylation as well as lipid metabolism 
as new potential regulation targets of H2S important 
for the Ras-ERK dependent DNMTs transcription.
General characterization of the DNMTs 
expression regulation
There are three active DNMTs in humans – DNMT1, 
DNMT3a, DNMT3b. DNMT1 catalyzes methyla-
tion per sample, saving methylation pattern during 
cell division. DNMT3a/3b are de novo methyltrans-
ferases. Two isoforms, DNMT2 and DNMT3L, 
show a very weak activity [20, 21]. The main func-
tion of DNA methylation is down-regulation of the 
gene expression. It is important for X-chromosome 
inactivation, gene imprinting, and cell-specific gene 
expression [22–24]. 
The regulation of DNMTs is performed at the 
transcriptional and post-transcriptional levels. There 
is an evidence of Sp1 and Sp3 transcriptional regula-
tion of DNMT1, DNMT3a, DNMT3b [25, 26], 
DNMT3b down-regulation by FOXO3a and 
DNMT3a down-regulation by p53 [27, 28]. Most of 
the studies are dedicated to the DNMT1 regulation. 
It is well known that the transcription of DNMT1 is 
regulated by Ras/AP-1 and RB/E2F signaling [29–
31]. It is also possible to observe phosphorylation by 
kinases С, α, βI, βII, δ, γ, η, ζ μ and acetylation by 
Tip60, HAUSP, UHRF1, HDAC1, PCNA as the 
main PTMs of DNMT1 [32–33]. 
So, DNMTs are under a tight control of cell sig-
naling at the transcriptional and protein biosynthesis 
levels. That is why the great prospects are opened for 
researches to affect DNA methylation through cell 
signaling pathways. Thus, the researches have a 
great potential to affect DNA methylation through 
cell signaling pathways.
General description of the DNMTs  
transcription regulation by the Ras-ERK 
signaling
ERK ½ (extracellular signal-regulated kinase), also 
known as p42 ⁄p44MAPK or MAPK1 and MAPK3, 
are isoforms of MAPK (mitogen-activated protein-
kinases) belonging to the family of proteins-trans-
duced signals from the plasma membrane to the nu-
cleus. The activation of plasma membrane receptors 
results in induction of the Ras-Raf-MEK-ERK phos-
phorylation cascade, which leads to ERK nucleus 
translocation and transcription initiation. However, 
besides their action in the nucleus, ERK are also im-
potent cytoplasmic signaling proteins [34].
There is a line of in vitro studies on the role of the 
Ras-ERK signaling regulation of the DNMTs tran-
scription [35–39]. The first studies were carried out 
with the human adrenocortical cancer and mouse 
embryonal teratocarcinoma cell lines [35, 36]. In the 
experiment with adrenocortical cell line bearing am-
plified ras gene, the authors demonstrated the Ras 
dependent DNMT1 expression at the transcriptional 
level [35]. The experiments with mouse embryonal 
teratocarcinoma showed similar results [36]. Both 
studies highlighted the AP-1 transcriptional regula-
tion of the dnmt1 gene promoter. It was shown that 
the gene promoter of dnmt1 bears AP-1 transcrip-
tional sites [37]. 
Besides the dnmt1 expression regulation through 
AP-1 transcriptional sites by ERK, there are two in 
vitro issues dwelling on the role of ERK in the tran-
scriptional regulation of DNMT 3a and DNMT3b 
employing unknown mechanisms [38, 39]. The ex-
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periments with TGF-b1 treatment of the prostate 
cancer cell line demonstrated the dependence of the 
ERK nuclear localization on DNMT1, DNMT3a, 
DNMT3b mRNA and protein expression [38]. The 
studies on the colon cancer cell line demonstrated no 
correlation between DNMT3a and DNMT3b ex-
pression levels regarding ERK and MEK activity 
and protein level, but showed such correlation for 
the DNMT1activity and the protein level [39].
Consequently, there is an evidence of strong de-
pendence of DNMT1 expression on the Ras-ERK 
signaling. Moreover, the mechanism of the DNMT1 
transcription regulation by ERK-AP-1 pathway is 
well described [29, 30, 38]. There are controversial 
data about [31, 32]. The data on DNMT3a and 
DNMT3b transcription by the Ras-ERK signaling 
are controversial, which gives room for further re-
search in the field.
H2S-dependent routes of the DNMTs  
transcription regulation by the Ras-ERK 
signaling 
Regulation of the Ras-ERK signaling-depen-
dent DNMTs transcription by sulfhydration 
H2S is a substrate of the cysteine residue sulfhydra-
tion reaction, PTM of proteins. There is a growing 
number of studies on the role of protein sulfhydra-
tion in the cell signaling [7]. Some of them are dedi-
cated to the Ras-ERK signaling dependence on the 
sulfhydration, the level of H2S concentration and the 
activity of H2S producing enzymes [41–43]. It is 
well-known that the ERK proteins dissociate from 
binding partner MEK and undergo activation-based 
phosphorylation to perform their function [35]. 
There are in vitro experiments that show the H2S de-
pendent ERK phosphorylation. For example, the 
treatment of mouse cardiomyocytes with H2S donor 
(NaHS) induces ERK phosphorylation, while inhibi-
tion of the endogenous production of the gas has an 
opposite effect [41]. The identical treatment condi-
tions for the mouse embryonal cortical neuron cul-
ture led to similar results [42]. Moreover, the authors 
use different inhibitors to show that the NaHS regu-
lation of ERK phosphorylation depends on the 
MEK1 activity. 
The mechanism of such H2S-dependent effect on 
ERK phosphorylation was later discovered by 
K. Zhao and his colleagues. This research group 
showed MEK1 sulfhydration at cysteine 341 in ex-
periments with the human endothelial cells, fibro-
blasts and CSE knockout mice. In these experiments 
MEK1 sulfhydration induced ERK phosphorylation 
and nucleus translocation [43]. 
In the light of the above-mentioned mechanism of 
DNMT1 transcription through AP-1 sites, H2S do-
nors and CBS or CSE inhibitors can affect MEK1 
sulfhydration and subsequent ERK activation and 
DNMT1 transcription. This field of research is open 
and may represent interest for further studies in mo-
lecular biology. 
Regulation of the Ras-ERK dependent DNMTs 
transcription by redox activity of H2S 
Several studies demonstrate the role of oxidative 
stress and ROS in the regulation of general DNMTs 
expression. For example, in vivo study demonstrates 
DNMT1, DNMT3b, but not DNMT3a upregulation 
and subsequent DNA hypermathylation as a result of 
neonatal hypoxia [44]. S.O. Lim and his colleagues 
detected in vitro ROS dependent Snail protein over-
expression, that regulates the HDAC1 and DNMT1 
immobilization on gene promoters. In this experi-
ment, the authors also identified the hypermethyl-
ation of E-cadherin gene promoter [45]. An interest-
ing study on the ROS regulation of the methylation 
protein machinery localization was carried out with 
the human embryonal carcinoma cell line [46]. 
A treatment of the cell culture with hydrogen perox-
ide (H2O2) results in the increase of SIRT1 and 
DNMT1 chromatin binding force as well as the 
methylation protein complex consisting of DNMT1, 
DNMT3B, SIRT1, EZH2 and γ-H2AX translocation 
to the transcriptional active genes, such as MYC, 
ACTB, TIMP3 and MLH1. [47].H2O2 treatment in-
duced the catalase gene promoter hypermethylation 
and downregulation of the gene expression, as de-
scribed in the study using hepatocellular carcinoma 
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cell line. A pre-treatment with antioxidant, N-acetyl-
cysteine, or DNMTs inhibitor 5-aza-deoxocytidine 
prevented the effect of H2O2 on the gene promoter 
methylation status and gene transcription [48]. 
Such sensitivity of DNMTs expression during 
oxidative stress could be referred to as a result of a 
well-known effect of oxidative stress on different 
cell signaling pathways, particularly the Ras-ERK 
signaling. Indeed, there are several PTMs of Ras and 
Raf by ROS. Ras is oxidized on cysteine 118; Raf 
cysteine-rich domain is also oxidized by ROS. Such 
events result in the Raf membrane immobilization 
and its subsequent activation [49–51]. There are also 
a few studies carried out with melanoma cell lines, 
which demonstrate ROS induction of the Ras-ERK 
dependent DNMT1 overexpression and DNA hyper-
methylation [52]. These data can prove our assump-
tion of an important role played by oxidative stress 
and thereby antioxidants in the Ras-ERK dependent 
DNMTs expression. 
There are a lot of studies on the role of antioxidant 
properties of H2S, such as ROS scavenging, SOD2, 
eNOS induction, etc. [8, 13]. Consequently, we hy-
pothesized that the ROS formation prevention by 
H2S could affect the Ras-ERK signaling and result in 
the methylation pattern modulation during oxidative 
stress. Indeed, there are some studies on the role of 
H2S in the Ras-ERK signaling regulation during oxi-
dative stress [17, 18]. For example, CoCl2 (the hy-
poxia mimetic) treatment of the myoblastic cell line 
could stimulate ROS formation and subsequent ERK 
activation. A pre-treatment with H2S donor, NaHS, 
and N-acetyl-l-cysteine could downregulate the ROS 
level and ERK activity [17]. Similar experiments 
with the pheochromocytoma cell line demonstrated 
the same results. The authors also discovered hy po-
xia-inducible factor-1 alpha (HIF-1α) down-regu la-
ted CBS expression. The pre-treatment with NaHS 
can compensate an effect of endogenous H2S and 
downregulate ERK activity in the oxidative stress 
conditions [18]. There is also one study, which shows 
that down-regulation of DNMT1, DNMT3a, 
DNMT3b expression levels after homocysteine 
treatment of endothelial cells was blocked by NaHS. 
The authors proved that H2S donors could regulate 
NADP+/NADPH balance and induce SOD2 expres-
sion, after which DNMTs expression is down-regu-
lated [19]. 
Thus, as it was mentioned above, there are several 
studies on the role of H2S in the regulation of DNMTs 
expression and the Ras-ERK signaling during oxida-
tive stress. However, there are no direct studies on 
the role of H2S in the regulation of Ras-ERK-
dependent DNMTs transcription in the oxidative 
stress conditions. It is very important to explore or to 
research the exact role H2S donors and inhibitors 
play in the regulation of Ras-ERK-dependent meth-
ylation pattern under oxidative stress. 
H2S regulation of the Ras-ERK signaling de-
pendent DNMTs transcription through NO 
Nitric oxide (NO) is also an endogenously produced 
gas regulating cell signaling along with H2S. A rate-
limiting enzyme of NO biosynthesis is nitric oxide 
synthase (NOS) in humans. NO is a substrate of 
protein nitrosylation and nitration. These PTMs are 
important for the enzymatic function of proteins 
[53]. The results of a series of experiments showed 
that H2S regulated the NOS expression and NO pro-
duction [19, 13–16]. It was demonstrated that H2S 
donors up-regulated the endothelial NOS expres-
sion and NO production by mouse aortic vascular 
smooth cells and the subsequent protein nitrosyl-
ation in vivo [13]. GSNO, an NO carrier, releases 
NO in the presence of H2S [14, 15]. The chemical 
reaction of H2S with NO results in the formation of 
bioactive nitrosothiols, which release NO in the 
presence of Cu2+. H2S and nitrite produce HSNO in 
the presence of endothelial cells or Fe3+-porphyrin. 
HSNO gene rates NO or HNO by the subsequent re-
action with H2S [16]. Another study demonstrates 
the inhibition of NOS and block of NO production 
by endothelial cells of the mouse brain in vitro [11]. 
Such property of H2S as NO induction could be im-
portant for the  DNMTs expression regulation, be-
cause a number of studies highlighted the role of 
NO in the regulation of DNA methylation. The first 
data appeared during the research of Duchenne 
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muscular dystrophy. The authors identified NO-
dependent global DNA me thy lation [53]. The re-
search of the causes of gastritis demonstrated H. 
Pylori bacteria infection stimulation of the macro-
phage NOS expression induced the NO-dependent 
DNA methylation in gastric mucosa [54, 55]. It is 
known that the gene promoter methylation causes 
the inhibition of transcription and there is evidence 
in the literature on the NO-dependent glo bal gene 
silencing in endothelial cells [56]. 
Hypothesizing the regulation of Ras-ERK-
dependent DNMTs expression, we assume that ni-
trosylation of the Ras-ERK pathway enzymes could 
represent the NO-dependent mechanisms of DNA 
methylation regulation. Indeed, Cys118 of Ras and 
Cys 183 of ERK are S-nitrosylated [57, 58]; tran-
scriptional factor targets of the Ras-ERK signaling 
pathways c-Fos and c-Jun (the elements of the AP-1 
transcriptional complex important for DNMTs 
transcription) are also nitrosylated on cysteine resi-
dues with subsequent block of AP-1 complex for-
mation [59, 60]. On the other hand, NO could dem-
onstrate an opposite effect on AP-1 complex ele-
ments stimulating c-Fos neurotrophin-dependent 
expression [61]. 
In other words, the hypothesis of H2S-dependent 
nitrosylation regulation of the Ras-ERK dependent 
DNMTs transcription is supported by appropriate li-
terature. However, this hypothesis requires additio-
nal scientific research to be proved completely. 
The role of H2S in the cholesterol-dependent 
regulation of the Ras-ERK signaling mediated 
DNMTs transcription 
Cholesterol is an important metabolite in humans at 
both body and cell level. Consequently, not a sur-
prise that cholesterol metabolism affects epigenetics, 
particularly DNA methylation pattern. It turned out 
that several studies had proved the effect of meva-
lonate pathway inhibitors – statins – on DNMTs ex-
pression; however, they provide no evidence of a 
direct role of the Ras-ERK signaling [62–64]. 
The first study showed that the treatment of breast 
cancer, prostate cancer and osteosarcoma cells with 
physiologically relevant concentrations of simvas-
tatin induced down-regulation on DNMT1 expres-
sion at the mRNA and protein levels [62]. The se-
cond one showed that the lovastatin treatment of 
colorectal cancer cells reduced the DNMTs level and 
BMP gene expression as a result of the gene pro-
moter demethylation [63]. There is another study 
which demonstrated that the acute myeloid leukemia 
cells treatment with simvastatin had exerted a dose-
dependent down-regulation effect on the DNMT1 
and DNMT1 level [64]. 
The above-mentioned effect of cholesterol deple-
tion could be explained by the Ras-ERK signaling 
modulation by this molecule. It is well known, that 
the plasms membrane (PM) structure is important 
for cell signaling. PM contains the so-called “lipid 
rafts”, which are composed of cholesterol and 
sphingolipids [65]. The lipid rafts harbor a lot of 
cell receptors and signaling proteins [66, 67]. The 
Ras proteins belong to PM proteins, activated in 
lipid rafts. It is discovered that a depletion of cho-
lesterol level in PM can block the Ras-ERK signa-
ling [67]. The Ras proteins are also farnasylated at 
Cys-185 and Cys-186 by the products of mevalo-
nate pathway of cholesterol biosynthesis, which is 
done to achieve activity. At the same time, the block 
of mevalonate pathway can inhibit the Ras-ERK 
signaling [68]. There is a need for additional studies 
to clarify a direct role of the Ras-ERK signaling 
modulation by cholesterol in the DNMTs transcrip-
tion regulation.
Fig. 2. Schematic representation of H2S-regulated PTMs of the 
Ras-ERK pathway enzymes (the author). 
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All in all, what is a potential role of H2S in the 
cholesterol-dependent Ras-ERK signaling mediated 
the DNMTs expression? The recent data shed the 
light on the role of sulfhydration in cholesterol me-
tabolism regulation. It is known that Sterol regulatory 
element-binging protein (SREBP) is a transcription 
factor which induces the transcription of cholesterol 
biosynthesis genes [69]. There are several stu dies 
which show that H2S stimulates the cholesterol bio-
synthesis through SREBP regulation [9–11]. For ex-
ample, a treatment of pancreas beta-cells with H2S 
donors, or the transfection with constitutional active 
cse gene induced up-regulation of (SREBP)-1c [9]. 
An adipocytes maturation is accompanied by the H2S 
biosynthesis genes overexpression. Moreover, this 
study indicates the main role of H2S in lipoge nesis 
[10]. It describes a CBS-dependent translocation of 
Sp1 to the nucleus and the SREBP gene promoter 
binding in the experiments with the ovarian cancer 
cells [11]. The research of the H2S dependent mecha-
nism of SREBP regulation results in the discovery of 
Sp1 sulfhydration at Cys68 and Cys755 [12]. 
Furthermore, the authors proved that such PTM is a 
driving force for SREBP up-regulation and subse-
quent lipogenesis through the regulation of Sp1 nu-
clear translocation and transcriptional activity [12]. 
Consequently, H2S donors and inhibitors of the 
gas biosynthesis could be promise agents in the cho-
lesterol metabolism regulation. There are some cho-
lesterol-dependent cell processes, which are relevant 
for the hypothesis of the review, and their regulation 
by H2S should be tested in future. The first one is the 
H2S-generated regulation of Ras-ERK-dependent 
DNMTs transcription through modulation of choles-
terol in a plasma membrane (PM). The second one is 
the H2S-generated regulation of the Ras-ERK de-
pendent DNMTs transcription through the modula-
tion of protein prenylation.
Conclusions 
The review presents the data which support our hy-
pothesis about H2S regulation of the Ras-ERK sig-
naling dependent DNMTs transcription. The relevant 
literature showed a series of experiments, whereby 
both H2S exogenous donors and endogenous gas 
could affect PTMs of Ras, Raf, MEK1 and ERK pro-
teins. H2S can regulate sulfhydration, oxidation, ni-
trosylation and prenylation thereby modulating the 
Ras-ERK signaling dependent and independent 
DNMTs expression in vitro and in vivo. We believe 
our hypothesis can be the basis for developing new 
drugs or transforming the existing treatment strate-
gies for different diseases associated with the DNA 
methylation disorders. There is a need for further 
studies to elucidate the detailed mechanisms of H2S 
impact on the Ras-ERK signaling dependent DNMTs 
transcription. 
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Потенційна роль сірководню (H2S) в регуляції залежної 
від Ras-ERK сигналізації транскрипції ДНК метилаз
Т. О. Нікітіна
Існують дані стосовно регуляції Ras-ERK клітинною сигналі-
зацією транскрипції ДНК метилтрансфераз (DNMTs). Також є 
дані стосовно ролі Н2S в регуляції активності Ras-ERK сигна-
лізації та експресії DNMTs. В представленому огляді висунута 
гіпотеза про те, що Н2S регулює Ras-ERK залежну транскрип-
цію DNMTs. Було продемонстровано, що окисний стрес , мета-
болізм ліпідів, сульфгідрування та нітрозилювання білків є го-
ловними цілями Н2S-опосередкованої регуляції. Дані клітинні 
процеси є важливими для після-трансляційної модифікації 
(ПТМ) ферментів Ras-ERK сигналізації. В огляді представлені 
дані, що демонструють залежність транскрипції DNMTs від 
Н2S-опосередкованої ПТМ ферментів Ras-ERK сигналізації. 
 К л юч ов і  с л ов а: Ras-ERK сигналізація, ДНК метилтранс-
ферази, Н2S.
Потенциальная роль сероводорода (H2S) в регуляции 
зависимой от Ras-ERK сигнализации ДНК метилаз
Т. А. Никитина
Существуют данные о регуляции Ras-ERK клеточной сигнализа-
цией транскрипции ДНК метилтрансфераз (DNMTs). Также есть 
данные о роли Н2S в регуляции активности Ras-ERK сигнализа-
ции и экспрессии DNMTs. В данном обзоре выдвинута гипотеза 
о том, что Н2S регулирует Ras-ERK-зависимую транскрипцию 
DNMTs. Было продемонстрировано, что окислительный стресс, 
метаболизм липидов, сульфгидрирование и нитрозилирование 
белков является главными целями H2S-опосрдованной регуля-
ции. Данные клеточные процессы являются важными для 
пост-транляционной модификации (ПТМ) ферментов Ras-ERK 
сигнализации. В обзоре представлены данные, демонстрирую-
щие зависимость транскрипции DNMTs от Н2S-опосредованной 
ПТМ ферментов Ras-ERK сигнализации. 
К л юч е в ы е  с л ов а: Ras-ERK сигнализации, ДНК метил-
трансферазы, Н2S.
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